{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:12:25Z","timestamp":1740136345767,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10787-023-01395-7","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T13:02:26Z","timestamp":1706965346000},"page":"1025-1038","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Observational analysis of the immunogenicity and safety of various types of spinal muscular atrophy vaccines"],"prefix":"10.1007","volume":"32","author":[{"given":"Guojuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3751-6607","authenticated-orcid":false,"given":"Heng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,3]]},"reference":[{"key":"1395_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bpobgyn.2021.02.002","volume":"76","author":"M Arora","year":"2021","unstructured":"Arora M, Lakshmi R (2021) Vaccines - safety in pregnancy. Best Pract Res Clin Obstet Gynaecol 76:23\u201340","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1395_CR2","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/S2214-109X(21)00497-6","volume":"10","author":"AO Bashorun","year":"2022","unstructured":"Bashorun AO, Badjie Hydara M, Adigweme I, Umesi A, Danso B, Johnson N, Sambou NA, Fofana S, Kanu FJ, Jeyaseelan V, Verma H, Weldon WC, Oberste MS, Sutter RW, Jeffries D, Wathuo M, Mach O, Clarke E (2022) Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia. Lancet Glob Health 10:e257\u2013e268","journal-title":"Lancet Glob Health"},{"key":"1395_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/21645515.2020.1764826","volume":"17","author":"J Bayliss","year":"2021","unstructured":"Bayliss J, Nissen M, Prakash D, Richmond P, Oh KB, Nolan T (2021) Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV\/Hib vaccine. Hum Vaccin Immunother 17:176\u2013190","journal-title":"Hum Vaccin Immunother"},{"key":"1395_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.vaccine.2019.10.064","volume":"38","author":"LC Bravo","year":"2020","unstructured":"Bravo LC, Carlos JC, Gatchalian SR, Montellano MEB, Tabora CFCB, Thierry-Carstensen B, Tingskov PN, S\u00f8rensen C, Wachmann H, Bandyopadhyay AS, Nielsen PI, Kusk MV (2020) Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: a phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age. Vaccine 38:530\u2013538","journal-title":"Vaccine"},{"key":"1395_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100540","volume":"27","author":"MR Capeding","year":"2020","unstructured":"Capeding MR, Sil A, Tadesse BT, Saluja T, Teshome S, Alberto E, Kim DR, Park EL, Park JY, Yang JS, Chinaworapong S, Park J, Jo SK, Chon Y, Yang SY, Ryu JH, Cheong I, Shim KY, Lee Y, Kim H, Lynch JA, Kim JH, Excler JL, Wartel TA, Sahastrabuddhe S (2020) Safety and immunogenicity of Vi-DT conjugate vaccine among 6\u201323-month-old children: phase II, randomized, dose-scheduling, observer-blind study. EClinicalMedicine 27:100540","journal-title":"EClinicalMedicine"},{"key":"1395_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/infdis\/jiaa770","volume":"226","author":"MR Capeding","year":"2022","unstructured":"Capeding MR, Gomez-Go GD, Oberdorfer P, Borja-Tabora C, Bravo L, Carlos J, Tangsathapornpong A, Uppala R, Laoprasopwattana K, Yang Y, Han S, Wittawatmongkol O (2022) Safety and immunogenicity of a new inactivated polio vaccine made from sabin strains: a randomized, double-blind, active-controlled, phase 2\/3 seamless study. J Infect Dis 226:308\u2013318","journal-title":"J Infect Dis"},{"key":"1395_CR7","doi-asserted-by":"publisher","first-page":"e1172","DOI":"10.1016\/S2214-109X(21)00205-9","volume":"9","author":"K Chumakov","year":"2021","unstructured":"Chumakov K, Ehrenfeld E, Agol VI, Wimmer E (2021) Polio eradication at the crossroads. Lancet Glob Health 9:e1172\u2013e1175","journal-title":"Lancet Glob Health"},{"key":"1395_CR8","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1016\/j.vaccine.2020.05.081","volume":"38","author":"JP Cramer","year":"2020","unstructured":"Cramer JP, Jimeno J, Han HH, Lin S, Hartmann K, Borkowski A, S\u00e1ez-Llorens X (2020) Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: a randomized, observer-blind, controlled phase 1\/2 trial. Vaccine 38:5313\u20135323","journal-title":"Vaccine"},{"key":"1395_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/14760584.2023.2161519","volume":"22","author":"A Dakin","year":"2023","unstructured":"Dakin A, Borrow R, Arkwright PD (2023) A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients. Expert Rev Vaccines 22:104\u2013117","journal-title":"Expert Rev Vaccines"},{"key":"1395_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(20)32541-1","volume":"397","author":"I De Coster","year":"2021","unstructured":"De Coster I, Leroux-Roels I, Bandyopadhyay AS, Gast C, Withanage K, Steenackers K, De Smedt P, Aerssens A, Leroux-Roels G, Oberste MS, Konopka-Anstadt JL, Weldon WC, Fix A, Konz J, Wahid R, Modlin J, Clemens R, Costa Clemens SA, Bachtiar NS, Van Damme P (2021) Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. Lancet 397:39\u201350","journal-title":"Lancet"},{"key":"1395_CR11","first-page":"336","volume":"69","author":"DE Leo","year":"2017","unstructured":"Leo DE, Cappelli V, Massaro MG, Tosti C, Morgante G (2017) Evaluation of the effects of a natural dietary supplement with cranberry, Noxamicina\u00ae and D-mannose in recurrent urinary infections in perimenopausal women. Minerva Ginecol 69:336\u2013341","journal-title":"Minerva Ginecol"},{"key":"1395_CR12","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268821000698","volume":"149","author":"MS Dhingra","year":"2021","unstructured":"Dhingra MS, Namazova-Baranova L, Arredondo-Garcia JL, Kim KH, Limkittikul K, Jantarabenjakul W, Perminova O, Kobashi IAR, Bae CW, Ojeda J, Park J, Chansinghakul D, B\u2019Chir S, Neveu D, Bonaparte M, Jordanov E (2021) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study. Epidemiol Infect 149:e90","journal-title":"Epidemiol Infect"},{"key":"1395_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1080\/14760584.2018.1506333","volume":"17","author":"RJ Duintjer Tebbens","year":"2018","unstructured":"Duintjer Tebbens RJ, Thompson KM (2018) Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine. Expert Rev Vaccines 17:739\u2013751","journal-title":"Expert Rev Vaccines"},{"key":"1395_CR14","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.vaccine.2020.01.007","volume":"38","author":"E Fadlyana","year":"2020","unstructured":"Fadlyana E, Dhamayanti M, Tarigan R, Mulia Sari R, Sjafri Bachtiar N, Kartasasmita CB, Rusmil K (2020) Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants. Vaccine 38:1962\u20131967","journal-title":"Vaccine"},{"key":"1395_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.4067\/S0716-10182020000600701","volume":"37","author":"LH Falleiros-Arlant","year":"2020","unstructured":"Falleiros-Arlant LH, Ayala SEG, Domingues C, Brea J, Colsa-Ranero A (2020) Current status of poliomyelitis in Latin America. Rev Chilena Infectol 37:701\u2013709","journal-title":"Rev Chilena Infectol"},{"key":"1395_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijid.2023.01.020","volume":"130","author":"G Feng","year":"2023","unstructured":"Feng G, Jiang D, Han W, Xie Z, Jiang Z, Huang L, Wang J, Zhang W, Xu L, Tan J, You W, Cui G, Li C, Wang Y (2023) Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months. Int J Infect Dis 130:20\u201327","journal-title":"Int J Infect Dis"},{"key":"1395_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biomedicines10010006","volume":"10","author":"C Ferlito","year":"2021","unstructured":"Ferlito C, Visco V, Biselli R, Cattaruzza MS, Carreras G, Salerno G, Lista F, Capobianchi MR, Castilletti C, Lapa D, Antonelli G, Gentile M, Sorice M, Riitano G, Lucania G, Riccieri V, Mainiero F, Angeloni A, Lucarelli M, Ferraguti G, Autore A, Lastilla M, Salemi S, Biondo MI, Picchianti-Diamanti A, Caporuscio S, Teloni R, Mariotti S, Nisini R, D\u2019Amelio R (2021) Safety of multiple vaccinations and durability of vaccine-induced antibodies in an Italian military cohort 5 years after immunization. Biomedicines 10:6","journal-title":"Biomedicines"},{"key":"1395_CR18","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/vaccines10122160","volume":"10","author":"S Fukushima","year":"2022","unstructured":"Fukushima S, Nakano T, Shimizu H, Hamada A (2022) Immunogenicity of catch-up immunization with conventional inactivated polio vaccine among Japanese adults. Vaccines (basel) 10:2160","journal-title":"Vaccines (basel)"},{"key":"1395_CR19","doi-asserted-by":"publisher","first-page":"2050106","DOI":"10.1080\/21645515.2022.2050106","volume":"18","author":"S Gao","year":"2022","unstructured":"Gao S, Wei M, Chu K, Li J, Zhu F (2022) Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants. Hum Vaccin Immunother 18:2050106","journal-title":"Hum Vaccin Immunother"},{"key":"1395_CR20","first-page":"503","volume":"398","author":"GBD","year":"2020","unstructured":"GBD (2020) Release 1, vaccine coverage collaborators (2021) measuring routine childhood vaccination coverage in 204 countries and territories, 1980\u20132019: a systematic analysis for the global burden of disease study 2020, release 1. Lancet 398:503\u2013521","journal-title":"Lancet"},{"key":"1395_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12936-021-03690-6","volume":"20","author":"M Gonz\u00e1lez-Silva","year":"2021","unstructured":"Gonz\u00e1lez-Silva M, Rabinovich NR (2021) Some lessons for malaria from the global polio eradication initiative. Malar J 20:210","journal-title":"Malar J"},{"key":"1395_CR22","doi-asserted-by":"publisher","first-page":"03103","DOI":"10.7189\/jogh.11.03103","volume":"11","author":"ZU Haq","year":"2021","unstructured":"Haq ZU, Rana MS (2021) Synergized immunization programming: Pakistan\u2019s road to polio eradication. J Glob Health 11:03103","journal-title":"J Glob Health"},{"key":"1395_CR23","first-page":"CD011780","volume":"12","author":"N Jaiswal","year":"2019","unstructured":"Jaiswal N, Singh S, Agarwal A, Chauhan A, Thumburu KK, Kaur H, Singh M (2019) Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis. Cochrane Database Syst Rev 12:CD011780","journal-title":"Cochrane Database Syst Rev"},{"key":"1395_CR24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.vaccine.2021.01.027","volume":"39","author":"R Jiang","year":"2021","unstructured":"Jiang R, Liu X, Sun X, Wang J, Huang Z, Li C, Li Z, Zhou J, Pu Y, Ying Z, Yin Q, Zhao Z, Zhang L, Lei J, Bao W, Jiang Y, Dou Y, Li J, Yang H, Cai W, Deng Y, Che Y, Shi L, Sun M (2021) Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population. Vaccine 39:1463\u20131471","journal-title":"Vaccine"},{"key":"1395_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0140-6736(20)32520-4","volume":"397","author":"A Juan-Giner","year":"2021","unstructured":"Juan-Giner A, Kimathi D, Grantz KH, Hamaluba M, Kazooba P, Njuguna P, Fall G, Dia M, Bob NS, Monath TP, Barrett AD, Hombach J, Mulogo EM, Ampeire I, Karanja HK, Nyehangane D, Mwanga-Amumpaire J, Cummings DAT, Bejon P, Warimwe GM, Grais RF (2021) Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. Lancet 397:119\u2013127","journal-title":"Lancet"},{"key":"1395_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijid.2020.07.019","volume":"99","author":"Z Li","year":"2020","unstructured":"Li Z, Xu J, Tan H, Zhang C, Chen J, Ni L, Yun X, Huang Y, Wang W (2020) Safety of pentavalent DTaP-IPV\/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017. Int J Infect Dis 99:149\u2013155","journal-title":"Int J Infect Dis"},{"key":"1395_CR27","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/infdis\/jiw433","volume":"214","author":"G Liao","year":"2016","unstructured":"Liao G, Li R, Li C, Sun M, Jiang S, Li Y, Mo Z, Xia J, Xie Z, Che Y, Yang J, Yin Z, Wang J, Chu J, Cai W, Zhou J, Wang J, Li Q (2016) Phase 3 trial of a sabin strain-based inactivated poliovirus vaccine. J Infect Dis 214:1728\u20131734","journal-title":"J Infect Dis"},{"key":"1395_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/vaccines10030472","volume":"10","author":"B Liu","year":"2022","unstructured":"Liu B, Cao B, Wang C, Han B, Sun T, Miao Y, Lu Q, Cui F (2022) Immunogenicity and safety of childhood combination vaccines: a systematic review and meta-analysis. Vaccines (basel) 10:472","journal-title":"Vaccines (basel)"},{"key":"1395_CR29","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.4269\/ajtmh.22-0271","volume":"107","author":"AL Lohiniva","year":"2022","unstructured":"Lohiniva AL, Nurzhynska A, Alhassan H, Shetye M, Ayiku P (2022) Understanding factors influencing polio vaccine uptake in Ghana-developing meaningful community mobilization and engagement strategies in collaboration with religious leaders. Am J Trop Med Hyg 107:1345\u20131350","journal-title":"Am J Trop Med Hyg"},{"key":"1395_CR30","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","volume":"19","author":"CL Lorson","year":"2010","unstructured":"Lorson CL, Rindt H, Shababi M (2010) Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 19:R111\u2013R118","journal-title":"Hum Mol Genet"},{"key":"1395_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100190","volume":"11","author":"S Mangarule","year":"2022","unstructured":"Mangarule S, Palkar S, Mitra M, Ravi MD, Singh R, Moureau A, Jayanth MV, Patel DM, Ravinuthala S, Patnaik BN, Jordanov E, Noriega F (2022) Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP\u223cT vaccine versus separate DTwP-HB-PRP\u223cT and IPV vaccines at 12\u201324 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP\u223cT in healthy infants in India. Vaccine X 11:100190","journal-title":"Vaccine X"},{"key":"1395_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1208\/s12249-022-02250-8","volume":"23","author":"I Mansoor","year":"2022","unstructured":"Mansoor I, Eassa HA, Mohammed KHA, Abd El-Fattah MA, Abdo MH, Rashad E, Eassa HA, Saleh A, Amin OM, Nounou MI, Ghoneim O (2022) Microneedle-based vaccine delivery: review of an emerging technology. AAPS PharmSciTech 23:103","journal-title":"AAPS PharmSciTech"},{"key":"1395_CR34","doi-asserted-by":"publisher","first-page":"S398","DOI":"10.1093\/infdis\/jiaa622","volume":"224","author":"JF Modlin","year":"2021","unstructured":"Modlin JF, Bandyopadhyay AS, Sutter R (2021) Immunization against poliomyelitis and the challenges to worldwide poliomyelitis eradication. J Infect Dis 224:S398\u2013S404","journal-title":"J Infect Dis"},{"key":"1395_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jiac.2019.11.012","volume":"26","author":"T Nakayama","year":"2020","unstructured":"Nakayama T, Vidor E, Tsuzuki D, Nishina S, Sasaki T, Ishii Y, Mizukami H, Tsuge H (2020) Immunogenicity and safety of a DTaP-IPV\/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan. J Infect Chemother 26:651\u2013659","journal-title":"J Infect Chemother"},{"key":"1395_CR36","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1111\/trf.15018","volume":"58","author":"MS Oberste","year":"2018","unstructured":"Oberste MS (2018) Progress of polio eradication and containment requirements after eradication. Transfusion 58:3078\u20133083","journal-title":"Transfusion"},{"key":"1395_CR37","first-page":"56","volume":"24","author":"X Qiu","year":"2004","unstructured":"Qiu X, Chen K, Tong L, Shu X, L\u00fc X, Wen H, Deng C (2004) Effects of moxibustion at shenque (CV 8) on serum IL-12 level and NK cell activities in mice with transplanted tumor. J Tradit Chin Med 24:56\u201358","journal-title":"J Tradit Chin Med"},{"key":"1395_CR38","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1016\/j.vaccine.2022.06.084","volume":"40","author":"X S\u00e1ez-Llorens","year":"2022","unstructured":"S\u00e1ez-Llorens X, Chan M, DeAntonio R, Petersen T, Olesen C, Jensen JS, S\u00f8rensen C, Ekstrand LM, Czort MK, Kristensen HH, Thulstrup N, Christoffersen DB (2022) Persistence of protective anti-poliovirus antibody levels in 4-year-old children previously primed with Picovax\u00ae, a trivalent, aluminium-adjuvanted reduced dose inactivated polio vaccine. Vaccine 40:5835\u20135841","journal-title":"Vaccine"},{"key":"1395_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpobgyn.2021.03.007","volume":"76","author":"M Sebghati","year":"2021","unstructured":"Sebghati M, Khalil A (2021) Uptake of vaccination in pregnancy. Best Pract Res Clin Obstet Gynaecol 76:53\u201365","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1395_CR40","doi-asserted-by":"publisher","first-page":"2146435","DOI":"10.1080\/21645515.2022.2146435","volume":"18","author":"H Sharma","year":"2022","unstructured":"Sharma H, Lalwani S, Parekh S, Pujari P, Shewale S, Palkar S, Hanumante N, Gokhale S, Ks J, Kumar R, Sharma I, Gairola S (2022) A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16\u201324 months. Hum Vaccin Immunother 18:2146435","journal-title":"Hum Vaccin Immunother"},{"key":"1395_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijid.2021.05.061","volume":"108","author":"SB Sirima","year":"2021","unstructured":"Sirima SB, Ouedraogo A, Barry N, Siribie M, Tiono A, N\u00e9bi\u00e9 I, Konat\u00e9 A, Berges GD, Diarra A, Ouedraogo M, Bougouma EC, Soulama I, Hema A, Datta S, Liang Y, Rotrosen ET, Tracy JK, Jamka LP, Oshinsky JJ, Pasetti MF, Neuzil KM, Laurens MB (2021a) Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial. Int J Infect Dis 108:465\u2013472","journal-title":"Int J Infect Dis"},{"key":"1395_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ijid.2020.10.103","volume":"102","author":"SB Sirima","year":"2021","unstructured":"Sirima SB, Ouedraogo A, Barry N, Siribie M, Tiono AB, N\u00e9bi\u00e9 I, Konat\u00e9 AT, Berges GD, Diarra A, Ouedraogo M, Soulama I, Hema A, Datta S, Liang Y, Rotrosen ET, Tracy JK, Jamka LP, Neuzil KM, Laurens MB (2021b) Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso. Int J Infect Dis 102:517\u2013523","journal-title":"Int J Infect Dis"},{"key":"1395_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.26719\/emhj.22.045","volume":"28","author":"MA Sultan","year":"2022","unstructured":"Sultan MA (2022) Emerging challenges to realizing global polio eradication and their solutions. East Mediterr Health J 28:515\u2013520","journal-title":"East Mediterr Health J"},{"key":"1395_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.905634","volume":"13","author":"X Sun","year":"2022","unstructured":"Sun X, Xu Y, Tang F, Xiao Y, Wang Z, Wang B, Zhu X, Yang X, Chen H (2022) Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: a multicenter, randomized, non-inferiority, controlled trial. Front Immunol 13:905634","journal-title":"Front Immunol"},{"key":"1395_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40272-019-00353-7","volume":"21","author":"YY Syed","year":"2019","unstructured":"Syed YY (2019) DTaP-IPV-HepB-Hib vaccine (Hexyon\u00ae): an updated review of its use in primary and booster vaccination. Paediatr Drugs 21:397\u2013408","journal-title":"Paediatr Drugs"},{"key":"1395_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/risa.13484","volume":"41","author":"KM Thompson","year":"2021","unstructured":"Thompson KM, Kalkowska DA (2021) Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame. Risk Anal 41:229\u2013247","journal-title":"Risk Anal"},{"key":"1395_CR47","first-page":"897","volume":"31","author":"ST Tseha","year":"2021","unstructured":"Tseha ST (2021) Polio: the disease that reemerged after six years in Ethiopia. Ethiop J Health Sci 31:897\u2013902","journal-title":"Ethiop J Health Sci"},{"key":"1395_CR48","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jamapediatrics.2018.2349","volume":"172","author":"N Wood","year":"2018","unstructured":"Wood N, Nolan T, Marshall H, Richmond P, Gibbs E, Perrett K, McIntyre P (2018) Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial. JAMA Pediatr 172:1045\u20131052","journal-title":"JAMA Pediatr"},{"key":"1395_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4314\/ahs.v20i1.28","volume":"20","author":"P Yamoah","year":"2020","unstructured":"Yamoah P, Bangalee V, Oosthuizen F (2020) A review of the safety of vaccines used in routine immunization in Africa. Afr Health Sci 20:227\u2013237","journal-title":"Afr Health Sci"},{"key":"1395_CR50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40121-022-00724-7","volume":"12","author":"K Yang","year":"2023","unstructured":"Yang K, Kim H, Ortiz E, Huoi C, Kang J (2023) Post-marketing safety surveillance of a childhood pentavalent diphtheria-tetanus-acellular pertussis-polio and haemophilus influenzae type B (DTaP-IPV\/\/Hib) vaccine in South Korea. Infect Dis Ther 12:499\u2013511","journal-title":"Infect Dis Ther"},{"key":"1395_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0140-6736(22)02397-2","volume":"401","author":"K Zaman","year":"2023","unstructured":"Zaman K, Bandyopadhyay AS, Hoque M, Gast C, Yunus M, Jamil KM, Mainou BA, Konopka-Anstadt JL, Hendley WS, Vincent A, Clemens R, Clemens SAC, Ross AG, Clemens JD, Tritama E (2023) Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial. Lancet 401:131\u2013139","journal-title":"Lancet"},{"key":"1395_CR52","doi-asserted-by":"publisher","first-page":"2160158","DOI":"10.1080\/21645515.2022.2160158","volume":"18","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Guo Y, Dong Y, Liu Y, Zhao Y, Yu S, Li S, Wu C, Yang B, Li W, Wei X, Zhang Y, Huang Y, Wang H, Yang X (2022) Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models. Hum Vaccin Immunother 18:2160158","journal-title":"Hum Vaccin Immunother"},{"key":"1395_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.21037\/atm-20-2537","volume":"9","author":"T Zhao","year":"2021","unstructured":"Zhao T, Mo Z, Ying Z, Huang T, Che Y, Li G, Yang X, Sun M, Jiang L, Shi L, Ye H, Zhao Z, Liu X, Li J, Li Y, Li R, Jiang R, Wang J, Fu Y, Ma R, Shi H, Yang H, Li C, Yang J, Li Q (2021) Post hoc analysis of two clinical trials to compare the immunogenicity and safety of different polio immunization schedules in Chinese infants. Ann Transl Med 9:253","journal-title":"Ann Transl Med"},{"key":"1395_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/vaccines10020254","volume":"10","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Ying Z, Zou Y, Zhu T, Qian D, Han W, Jiang Y, Jiang Z, Li X, Wang J, Lei J, Xu L, Jiang D, Li C, Liu X (2022) Safety, immunogenicity and lot-to-lot consistency of sabin-strain inactivated poliovirus vaccine in 2-month-old infants: a double-blind. Randomized phase III trial. Vaccines (basel) 10:254","journal-title":"Vaccines (basel)"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01395-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T14:15:16Z","timestamp":1712758516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01395-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01395-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2024,2,3]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Ethics Committee of Heilongjiang Provincial Hospital. All methods were conducted in accordance with relevant guidelines and regulations. All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from the parents of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}